Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics tags : Publication save search
Chemomab Reports New Peer-Reviewed Publication Reinforcing the Clinical Association of Its CCL24 Target with Disease Severity and Mortality in Patients with Systemic Sclerosis
Published: 2024-04-18 (Crawled : 11:00) - globenewswire.com
CMMB | News | $0.691 -1.29% -1.3% 15K
|
Manufacturing
|
| O: -3.38%
H: 0.0%
C: 0.0%
ccl24 disease association publication sclerosis
BrainStorm Cell Therapeutics Announces Peer-reviewed Publication of Biomarker Data from NurOwn's® Phase 3 Clinical Trial in ALS
Published: 2024-04-10 (Crawled : 10:00) - prnewswire.com
BCLI | $0.5384 4.69% 4.48% 1M
|
Health Technology
|
| O: -20.14%
H: 0.0%
C: 0.0%
als biomarker publication cell trial therapeutics
Tempest Announces Publication of Positive Data from Phase 1 Trial of TPST-1120 in Patients with Advanced Solid Tumors in Journal of Cancer Research Communications
Published: 2024-04-04 (Crawled : 12:00) - globenewswire.com
TPST | $3.105 -2.05% -2.09% 380K
|
Manufacturing
|
| O: 8.39%
H: 2.71%
C: -12.96%
tpst-1120 tumors positive cancer publication research communications trial advanced
Virios Therapeutics Announces Publication of International Patent for IMC-2 Covering Antiviral Treatment of Long-COVID
Published: 2024-03-26 (Crawled : 13:00) - globenewswire.com
VIRI | $0.4393 -2.36% -2.41% 59K
|
Health Technology
|
| O: 4.41%
H: 8.05%
C: -12.31%
patent antiviral international publication treatment therapeutics
United Therapeutics Announces the First Comprehensive Review Publication on Xenotransplantation
Published: 2024-03-26 (Crawled : 12:30) - biospace.com/
UTHR | $237.99 0.45% 0.45% 400K
|
Health Technology
|
| O: 0.17%
H: 2.54%
C: 1.3%
first review publication therapeutics
Tenaya Therapeutics Announces Publication of TN-401 Gene Therapy Preclinical Data in Nature Communications Medicine
Published: 2024-03-18 (Crawled : 12:30) - globenewswire.com
TNYA | $4.31 0.47% 0.46% 410K
|
|
| O: -0.9%
H: 9.33%
C: -2.23%
tn-401 publication preclinical communications therapeutics therapy
Autolus Therapeutics announces publication in Blood Cancer Journal
Published: 2024-03-11 (Crawled : 11:00) - globenewswire.com
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
|
| O: -0.09%
H: 1.13%
C: -0.08%
AUTL | $4.51 -6.04% -6.43% 1.4M
|
Health Technology
|
| O: 0.7%
H: 1.49%
C: -5.91%
cancer publication blood therapeutics
Akero Therapeutics Announces Publication of Phase 2b SYMMETRY Cohort D Study in Clinical Gastroenterology and Hepatology
Published: 2024-03-07 (Crawled : 21:00) - globenewswire.com
AKRO | $20.76 1.22% 1.2% 790K
|
Health Technology
|
| O: 0.16%
H: 5.27%
C: 0.81%
publication therapeutics study
AceLink Therapeutics Announces Publication of Phase 1 Clinical Trial Data Evaluating AL01211 in Healthy Volunteers
Published: 2024-02-26 (Crawled : 15:30) - biospace.com/
BW | News | $0.9279 -4.18% 0.0% 1.1M
|
Electronic Technology
|
| O: 0.0%
H: 3.7%
C: 0.93%
al0121 publication trial therapeutics
Tenaya Therapeutics Announces Publication of Preclinical HDAC6 Inhibitor Data for Heart Failure with Preserved Ejection Fraction in Nature Communications
Published: 2024-02-26 (Crawled : 13:30) - globenewswire.com
TNYA | $4.31 0.47% 0.46% 410K
|
|
| O: -1.34%
H: 11.07%
C: 10.49%
publication preclinical communications heart therapeutics
Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy
Published: 2024-02-22 (Crawled : 13:30) - globenewswire.com
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: 1.73%
H: 1.14%
C: -0.57%
ATXI | $0.1295 -3.79% -3.94% 320K
|
Health Technology
|
| O: -2.95%
H: 2.62%
C: -1.93%
baer-101 drug publication research preclinical therapeutics
Autolus Therapeutics announces publication in Nature Communications
Published: 2024-02-22 (Crawled : 12:00) - globenewswire.com
AUTL | $4.51 -6.04% -6.43% 1.4M
|
Health Technology
|
| O: 0.97%
H: 0.64%
C: -3.04%
publication therapeutics
TransCode Therapeutics Reports Publication of United States Patent Application Covering TransCode’s RIG-I Agonist Immunotherapeutic
Published: 2024-02-20 (Crawled : 13:00) - globenewswire.com
RNAZ | $0.49 -2.39% -2.45% 110K
|
Professional, Scientific, and T...
|
| O: 1.87%
H: 0.0%
C: -1.84%
patent agonist publication application therapeutics
Athira Pharma Announces Publication in Frontiers in Neuroscience Highlighting Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS)
Published: 2024-02-08 (Crawled : 21:00) - globenewswire.com
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: 1.89%
H: 3.72%
C: 2.79%
ath-1105 pharma publication sclerosis potential
New Publication Identifies Key Proteins Involved in Amyloid Oligomer Binding and Supports Mechanism of CT1812
Published: 2024-02-06 (Crawled : 14:00) - globenewswire.com
CGTX | $1.86 1.09% 1.08% 120K
|
|
| O: 1.3%
H: 5.14%
C: -3.85%
ct1812 publication key
New Publication in Nature Medicine Supports Therapeutic Potential of Senolytics to Provide Long-lasting, Disease-modifying Intervention in Vision Loss
Published: 2024-02-06 (Crawled : 13:00) - globenewswire.com
UBX | $1.5 -0.66% -0.67% 45K
|
Health Technology
|
| O: 0.0%
H: 3.57%
C: 2.98%
publication potential
Nurix Therapeutics Announces Publication in the Journal Science Identifying a New Class of BTK Mutations That Are Susceptible to NX-2127, a Novel BTK and IKZF1/3 Degrader
Published: 2024-02-01 (Crawled : 21:00) - globenewswire.com
NRIX 2 d | $13.6 -5.82% -6.18% 1M
|
Health Technology
|
| O: -0.49%
H: 1.48%
C: 0.37%
nx-2127 publication therapeutics
Intellia Therapeutics Announces Publication of Positive Interim Phase 1 Data for NTLA-2002 in Patients with Hereditary Angioedema in the New England Journal of Medicine
Published: 2024-01-31 (Crawled : 22:00) - globenewswire.com
NTLA | $21.57 1.17% 1.16% 1.4M
|
Health Technology
|
| O: 0.88%
H: 8.11%
C: 5.12%
ntla-2002 positive publication therapeutics
Cadrenal Therapeutics Highlights Publication of Peer-Reviewed Article Supporting Need for New Anticoagulation Therapy for Patients with Certain Medical Conditions
Published: 2024-01-31 (Crawled : 15:30) - biospace.com/
CVKD | $0.401 -6.7% -7.18% 67K
|
|
| O: -1.79%
H: 12.12%
C: 10.3%
publication medical therapeutics therapy
ZyVersa Therapeutics Highlights Publication Indicating That Inflammasome NLRP3-Mediated Inflammation in Obese Children Leads to Insulin Resistance and Risk of Complications Such as Type 2 Diabetes
Published: 2024-01-31 (Crawled : 13:00) - globenewswire.com
ZVSA | $0.581 -7.19% -7.75% 280K
|
|
| O: -4.07%
H: 7.97%
C: -3.37%
children publication risk therapeutics diabetes insulin
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
UONE | $2.36 19.8% 16.53% 75K
|
Consumer Services
Your saved searches
Save your searches and get alerts when important news are released.